Contact information
Research groups
Websites
-
Translational Dermatology Unit
Research Unit
-
MRC Translational Immune Discovery Unit
Research Unit
-
MRC Weatherall Institute of Molecular Medicine
Research Institute
Graham Ogg
FMedSci
Professor of Dermatology
CD1a; Skin immunology; T cells; innate lymphoid cells
CD1a, T cells and the skin
Skin and mucosae frequently represent the first point of contact with pathogens and allergens, yet we still know relatively little of the role of the surface immune system in clearing such challenges. This is crucially important in understanding the mechanisms of skin diseases and related diseases, and for optimising approaches to cutaneous drug and vaccine delivery. The aim of the group is therefore to understand, at the molecular and cellular level, the role of human cutaneous immune responses in mechanisms of disease, treatment and vaccination. As well as contributing to an understanding of disease pathogenesis, we aim to translate our findings to changes in clinical practice.
Specifically, we are working on skin T cells which respond to inflammatory lipids that are presented by CD1a. This turns out to be a very important part skin immune responses and we have been defining the underlying mechanisms. Our findings are also developing towards new approaches to modulate the CD1a pathway for patient benefit.
Recent publications
-
Sideways lipid presentation by the antigen-presenting molecule CD1c.
Journal article
Cao T-P. et al, (2025), Nat Commun
-
Long-persisting SARS-CoV-2 spike-specific CD4+ T cells associated with mild disease and increased cytotoxicity post COVID-19.
Journal article
Liu G. et al, (2025), Nat Commun, 16
-
Can AlphaFold's breakthrough in protein structure help decode the fundamental principles of adaptive cellular immunity?
Journal article
McMaster B. et al, (2024), Nat Methods, 21, 766 - 776
-
Identification of differences in the magnitude and specificity of SARS-CoV-2 nucleocapsid antibody responses in naturally infected and vaccinated individuals.
Journal article
Pushpakumara PD. et al, (2024), Clin Exp Immunol, 215, 268 - 278
-
Pre-existing asthma as a comorbidity does not modify cytokine responses and severity of COVID-19
Preprint
Luo J. et al, (2024)